Glycogen storage disease type III MRI
Jump to navigation
Jump to search
|
Glycogen storage disease type III Microchapters |
|
Differentiating Glycogen storage disease type III from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type III MRI On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type III MRI |
|
Risk calculators and risk factors for Glycogen storage disease type III MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Abdominal magnetic resonance imaging or computed tomography with contrast is performed to screen for evidence of liver cirrhosis, hepatic adenoma, and hepatocellular carcinoma.
MRI
- Abdominal magnetic resonance imaging or computed tomography with contrast is performed to screen for:[1]
- Evidence of liver cirrhosis (nodular hepatic contour and manifestations of portal venous hypertension such as splenomegaly)
- Presence of adenomas
- Evidence of hepatocellular carcinoma
- Patients to be screened include:
- Pediatric age group once adenoma is detected on ultrasound
- Older patients even if there is no adenoma on ultrasound
- These investigations should be repeated every 6 - 12 months or earlier on the basis of laboratory and clinical findings.
References
- ↑ Kishnani, Priya S; Austin, Stephanie L; Arn, Pamela; Bali, Deeksha S; Boney, Anne; Case, Laura E; Chung, Wendy K; Desai, Dev M; El-Gharbawy, Areeg; Haller, Ronald; Smit, G Peter A; Smith, Alastair D; Hobson-Webb, Lisa D; Wechsler, Stephanie Burns; Weinstein, David A; Watson, Michael S (2010). "Glycogen Storage Disease Type III diagnosis and management guidelines". Genetics in Medicine. 12 (7): 446–463. doi:10.1097/GIM.0b013e3181e655b6. ISSN 1098-3600.